Down-regulated expression of lncRNA MEG3 is involved in cisplatinum resistance through p53 and Bcl-xl controlled gene expression in lung carcinoma cells [45], although additional epigenetic evidences must be obtained in lung cancer patients. Here, MEG3 is linked to lung cancer.